Clinical significance of loss of heterozygosity on M6P/IGF2R in primary hepatocellular carcinoma

被引：0
|
作者：
Kang, Ki Mun
Jang, Hong Seok
Choi, Byung Ock
Lee, Sang Wook
Hong, Soon Chan
Chai, Gyu Young
机构：
[1] Gyeongsang Natl Univ, Coll Med, Radiat Oncol, Jinju, South Korea
[2] Catholic Univ Korea, Coll Med, Radiat Oncol, Seoul, South Korea
[3] Univ Ulsan, Asan Med Ctr, Radiat Oncol, Seoul, South Korea
[4] Gyeongsang Natl Univ, Coll Med, Surg, Jinju, South Korea
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
922
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Primary tumor loss of heterozygosity proximal to M6P/IGF2R locus is predictive for the presence and persistence of disseminated tumor cells in the bone marrow of ovarian cancer patients
    Kuhlmann, Jan D.
    Schwarzenbach, Heidi
    Otterbach, Friedrich
    Heubner, Martin
    Wimberger, Pauline
    Worm, Karl H.
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    CANCER RESEARCH, 2011, 71
  • [22] M6P/IGF2R tumor suppressor gene mutation in esophageal squamous cell carcinoma.
    Hisabe, T
    Sultan, S
    Jirtle, RL
    Oka, Y
    Matsui, T
    Yao, T
    Iwashita, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1180S - 1180S
  • [23] 肺鳞状细胞癌的M6P/IGF2R突变
    王蓉
    国外医学遗传学分册., 2001, (05) : 284 - 285
  • [24] High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer
    Huang, ZQ
    Wen, YQ
    Shandilya, R
    Marks, JR
    Berchuck, A
    Murphy, SK
    NUCLEIC ACIDS RESEARCH, 2006, 34 (02) : 555 - 563
  • [25] Loss of Heterozygosity Proximal to the M6P/IGF2R Locus Is Predictive for the Presence of Disseminated Tumor Cells in the Bone Marrow of Ovarian Cancer Patients Before and After Chemotherapy
    Kuhlmann, Jan Dominik
    Schwarzenbach, Heidi
    Otterbach, Friedrich
    Heubner, Martin
    Wimberger, Pauline
    Worm, Karl-Heinz
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    GENES CHROMOSOMES & CANCER, 2011, 50 (08): : 598 - 605
  • [26] Hepatocellular carcinomas in tyrosinemia type I patients have a mutated M6P/IGF2R tumor suppressor gene.
    Oka, Y
    Killian, JK
    Remotti, H
    Jirtle, RL
    HEPATOLOGY, 2000, 32 (04) : 413A - 413A
  • [27] Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation
    Leksa, Vladimir
    Loewe, Robert
    Binder, Brigitte
    Schiller, Herbert B.
    Eckerstorfer, Paul
    Forster, Florian
    Soler-Cardona, Ana
    Ondrovicova, Gabriela
    Kutejova, Eva
    Steinhuber, Eva
    Breuss, Johannes
    Drach, Johannes
    Petzelbauer, Peter
    Binder, Bernd R.
    Stockinger, Hannes
    CIRCULATION RESEARCH, 2011, 108 (06) : 676 - U323
  • [28] 抑癌基因m6p/igf2r的研究进展附视频
    刘渊
    肿瘤防治研究, 2002, (06) : 502 - 503
  • [29] Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis
    Martin-Kleiner, Irena
    Troselj, Koraljka Gall
    CANCER LETTERS, 2010, 289 (01) : 11 - 22
  • [30] Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury
    Kong, FM
    Anscher, MS
    Sporn, TA
    Washington, MK
    Clough, R
    Barcellos-Hoff, MH
    Jirtle, RL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (01): : 35 - 41
12345